Medicare Part D coverage · fezolinetant · RxCUI 2637147
fezolinetant 45 MG Oral Tablet [Veozah]
Per the CMS 2026 Part D formulary file, fezolinetant 45 MG Oral Tablet [Veozah] is covered by 2,224 Medicare Part D plans (44% of enrollable products), averaging Tier 3.5, with prior authorization required on 95.5% of covering formularies.
- 44%
- Plan coverage
- 2,224
- Plans covering
- T3.5
- Avg tier
- 95.5%
- Prior auth required
What the CMS Formulary Data Shows for fezolinetant 45 MG Oral Tablet [Veozah]
Per the CMS 2026 Part D formulary file, fezolinetant 45 MG Oral Tablet [Veozah] (RxNorm concept RXCUI 2637147, generic name fezolinetant) appears on 177 distinct formulary files spanning 2,224 Medicare Part D plan offerings - 44% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.5.
Real-world access to fezolinetant 45 MG Oral Tablet [Veozah] depends on utilization management as much as tier placement: 95.5% of covering formularies require prior authorization. 0.6% require step therapy. 85.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,837 Part D beneficiaries filled fezolinetant 45 MG Oral Tablet [Veozah] in 2023, with total plan-and-beneficiary spending of $4,494,558 and an average per-beneficiary annual cost of $1,584.26. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry fezolinetant 45 MG Oral Tablet [Veozah] today.
Coverage Details
- Formularies covering
- 177
- Plans covering
- 2,224
- Coverage rate
- 44%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 95.5% of formularies
- Step therapy required
- 0.6% of formularies
- Quantity limits
- 85.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 2,837
- Total spending
- $4,494,558
- Avg per beneficiary
- $1,584.26
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering fezolinetant 45 MG Oral Tablet [Veozah]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Horizon NJ TotalCare (HMO D-SNP) | Horizon Healthcare OF NEW Jersey, Inc. | T1 | Yes | $0 | NJ |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | Yes | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | Yes | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | Yes | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | Yes | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | Yes | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | Yes | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | Yes | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | Yes | $0 | MO |
Show the next 30 plans
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | No | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | Yes | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | Yes | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | Yes | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | Yes | $0 | MA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | Yes | $4.80 | TX |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | Yes | $4.80 | FL |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | Yes | $4.80 | TX |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | Yes | $5.00 | OK |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $8.90 | AR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | Yes | $10.50 | OR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | Yes | $10.50 | OR |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $13.10 | PA |
| Provider Partners Illinois Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Illinois | T1 | Yes | $15.20 | IL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | Yes | $17.00 | AZ |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $17.60 | PA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is fezolinetant 45 MG Oral Tablet [Veozah] covered by Medicare Part D?
Yes, fezolinetant 45 MG Oral Tablet [Veozah] is covered by 2,224 Medicare Part D plans (44% of all Part D formularies).
What tier is fezolinetant 45 MG Oral Tablet [Veozah] on Medicare Part D plans?
fezolinetant 45 MG Oral Tablet [Veozah] averages Tier 3.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does fezolinetant 45 MG Oral Tablet [Veozah] require prior authorization?
95.5% of Part D formularies require prior authorization for fezolinetant 45 MG Oral Tablet [Veozah]. Step therapy: 0.6%. Quantity limits: 85.3%.
How much does Medicare spend on fezolinetant 45 MG Oral Tablet [Veozah]?
In 2023, total Medicare Part D spending on fezolinetant 45 MG Oral Tablet [Veozah] was $4,494,558, covering 2,837 beneficiaries. The average spend per beneficiary was $1,584.26.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- alanine 5.4 MG/ML / arginine 12 MG/ML / aspartate 3.2 MG/ML / cysteine 0.24 MG/ML / glutamate 5 MG/ML / glycine 3.6 MG/ML / histidine 4.8 MG/ML / isoleucine 8.2 MG/ML / leucine 1.4 MG/ML / lysine 1.2 MG/ML / methionine 3.4 MG/ML / phenylalanine 4.8 MG/ML / proline 6.8 MG/ML / serine 3.8 MG/ML / sodium acetate 0.097 MEQ/ML / sodium chloride 0.003 MEQ/ML / sodium metabisulfite 0.5 MG/ML / taurine 0.25 MG/ML / threonine 4.2 MG/ML / tryptophan 2 MG/ML / tyrosine 2.84 MG/ML / valine 7.8 MG/ML Injectable Solution [Trophamine 10 %] T3.5
- alanine 8.8 MG/ML / arginine 4.89 MG/ML / calcium chloride 0.004 MEQ/ML / dibasic potassium phosphate 2.61 MG/ML / glucose 50 MG/ML / glycine 4.38 MG/ML / histidine 2.04 MG/ML / isoleucine 2.55 MG/ML / leucine 3.11 MG/ML / lysine 2.47 MG/ML / magnesium chloride 0.01 MEQ/ML / methionine 1.7 MG/ML / phenylalanine 2.38 MG/ML / proline 2.89 MG/ML / serine 2.13 MG/ML / sodium acetate trihydrate 2.97 MG/ML / sodium chloride 0.013 MEQ/ML / threonine 1.79 MG/ML / tryptophan 0.77 MG/ML / tyrosine 0.17 MG/ML / valine 2.47 MG/ML Injectable Solution [Clinimix E 4.25/5] T3.5
- amoxicillin 25 MG/ML / clavulanate 6.25 MG/ML Oral Suspension [Augmentin] T3.5
- latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [Vyzulta] T3.5
- imatinib 400 MG Oral Tablet T3.4
- 500 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid] T3.4
Similar prior-authorization rate
- fostamatinib 100 MG Oral Tablet [Tavalisse] 95.5% PA
- 0.5 ML pegvaliase-pqpz 20 MG/ML Prefilled Syringe [Palynziq] 95.5% PA
- 1 ML pegvaliase-pqpz 20 MG/ML Prefilled Syringe [Palynziq] 95.5% PA
- sapropterin dihydrochloride 500 MG Powder for Oral Solution 95.6% PA
- maralixibat 10 MG Oral Tablet [Livmarli] 95.2% PA
- deflazacort 22.75 MG/ML Oral Suspension 95.8% PA